Information Provided By:
Fly News Breaks for June 17, 2019
FLDM
Jun 17, 2019 | 14:11 EDT
Piper Jaffray analyst William Quirk reiterated an Overweight rating and $16 price target on Fluidigm after the company announced seven new metal markers for its Mass Cytometry offering, making the system capable of supporting up to 50 parameters at a time. Quirk sees this announcement solidifies Fluidigm's competitive position, and leaves the company in a position to "exceed Street expectations on the strength of Mass Cytometry." The analyst also believes the company is closing in on Microfluidics stability.
News For FLDM From the Last 2 Days
There are no results for your query FLDM
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.